GSK plc announced the completion of its previously announced acquisition of efimosfermin alfa from Boston Pharmaceuticals. Efimosfermin is a phase III-ready, potential best-in-class investigational ...

Schott Pharma, a pioneer in drug containment solutions and delivery systems, announced that it has added a Knowledge Hub to its Pharmaversity, which was established in 2020 as a pharmaceutical ...